Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity, 57707 [2022-20436]
Download as PDF
<![CDATA[
57707
Federal Register / Vol. 87, No. 182 / Wednesday, September 21, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Type of respondents
Data Access Request .......................
Institutional Signing Official to Certify Request.
Number of
responses per
respondent
3,900
Average
burden per
response
(in hours)
Total annual
burden hours
10
30/60
19,500
Project Renewal or Project Close-out
Project Renewal or Project Close-out
form.
Project Renewal or Project Close-out
form.
Requester Submitting Request ........
3,900
10
15/60
9,750
Institutional Signing Official to Certify Request.
3,900
10
18/60
11,700
Total ...........................................
...........................................................
18,750
159,150
........................
72,301
Dated: September 15, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2022–20467 Filed 9–20–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2022 Notice of
Supplemental Funding Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting an
administrative supplement (in scope of
the parent award) up to $20,833 (total
costs) for one-year to the Improving
Access to Overdose Treatment grant
recipients for a total of up to $104,165
(total funding). These recipients were
funded in FY 2018 with a project end
date of September 30, 2023. The
supplemental funding will be utilized
specifically to increase the number of
health care providers and pharmacists
who receive training and technical
assistance on the prescribing of drugs or
devices approved or cleared under the
FDA for emergency treatment of known
or suspected opioid overdose.
FOR FURTHER INFORMATION CONTACT:
Judith Ellis, Substance Abuse and
Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD
20857, telephone (240) 276–2567; email:
judith.ellis@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION: Awardees
will further collaborations with
healthcare providers and pharmacists to
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:54 Sep 20, 2022
Jkt 256001
educate them on overdose dangers and
standing orders for FDA-approved
overdose reversal drugs to patients and
individuals who support persons at
high-risk for overdose.
The required activities for this
supplement are as follows:
• Increase use of SAMHSA’s Opioid
Overdose Prevention Toolkit as a guide
to develop and implement a
comprehensive prevention program to
reduce the number of prescription drug/
opioid overdose-related deaths and
adverse events among cases of known or
suspected opioid overdose.
• Provide technical assistance to
collaborating partner organizations and
practitioners in the implementation of a
comprehensive prevention program to
reduce the number of prescription drug/
opioid overdose-related deaths and
adverse events.
• Collaborate with additional
pharmacies to distribute drugs or
devices approved or cleared under the
Federal Food, Drug, and Cosmetic Act
for emergency treatment of known or
suspected opioid overdose, as permitted
by state law.
• Provide targeted public education
on the state’s ‘‘Good Samaritan’’ laws
related to a drug overdose, if applicable,
such as those that permit bystanders to
alert emergency responders to an
overdose or to administer drugs or
devices approved or cleared under the
Federal Food, Drug, and Cosmetic Act
for emergency treatment of known or
suspected opioid overdose without fear
of civil or criminal penalties.
This is not a formal request for
application. Assistance will only be
provided to the Improving Access to
Overdose Treatment Funding
Opportunity SP–18–006 grant recipients
based on the receipt of a satisfactory
application and associated budget that
is approved by a review group.
Funding Opportunity Title: FY 2018
Improving Access to Overdose
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Treatment Funding Opportunity SP–18–
006.
Assistance Listing Number: 93.243.
Authority: Section 516 of the Public
Health Services Act, as amended.
Justification: Eligibility for this
supplemental funding is limited the
Improving Access to Overdose
Treatment Funding Opportunity SP–18–
006 grant recipients funded in FY 2018.
These organizations are uniquely
positioned to provide training and
technical assistance to organizations
and practitioners in prescription drug
overdose prevention activities being
funded through this supplement.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–20436 Filed 9–20–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–4665–
DR; Docket ID FEMA–2022–0001]
Missouri; Major Disaster and Related
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security (DHS).
ACTION: Notice.
AGENCY:
This is a notice of the
Presidential declaration of a major
disaster for the State of Missouri
(FEMA–4665–DR), dated August 8,
2022, and related determinations.
DATES: The declaration was issued
August 8, 2022.
FOR FURTHER INFORMATION CONTACT:
Dean Webster, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street SW,
Washington, DC 20472, (202) 646–2833.
SUMMARY:
E:\FR\FM\21SEN1.SGM
21SEN1
]]>Agencies
[Federal Register Volume 87, Number 182 (Wednesday, September 21, 2022)]
[Notices]
[Page 57707]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20436]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice of intent to award supplemental funding.
-----------------------------------------------------------------------
SUMMARY: This notice is to inform the public that the Substance Abuse
and Mental Health Services Administration (SAMHSA) is supporting an
administrative supplement (in scope of the parent award) up to $20,833
(total costs) for one-year to the Improving Access to Overdose
Treatment grant recipients for a total of up to $104,165 (total
funding). These recipients were funded in FY 2018 with a project end
date of September 30, 2023. The supplemental funding will be utilized
specifically to increase the number of health care providers and
pharmacists who receive training and technical assistance on the
prescribing of drugs or devices approved or cleared under the FDA for
emergency treatment of known or suspected opioid overdose.
FOR FURTHER INFORMATION CONTACT: Judith Ellis, Substance Abuse and
Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD
20857, telephone (240) 276-2567; email: [email protected].
SUPPLEMENTARY INFORMATION: Awardees will further collaborations with
healthcare providers and pharmacists to educate them on overdose
dangers and standing orders for FDA-approved overdose reversal drugs to
patients and individuals who support persons at high-risk for overdose.
The required activities for this supplement are as follows:
Increase use of SAMHSA's Opioid Overdose Prevention
Toolkit as a guide to develop and implement a comprehensive prevention
program to reduce the number of prescription drug/opioid overdose-
related deaths and adverse events among cases of known or suspected
opioid overdose.
Provide technical assistance to collaborating partner
organizations and practitioners in the implementation of a
comprehensive prevention program to reduce the number of prescription
drug/opioid overdose-related deaths and adverse events.
Collaborate with additional pharmacies to distribute drugs
or devices approved or cleared under the Federal Food, Drug, and
Cosmetic Act for emergency treatment of known or suspected opioid
overdose, as permitted by state law.
Provide targeted public education on the state's ``Good
Samaritan'' laws related to a drug overdose, if applicable, such as
those that permit bystanders to alert emergency responders to an
overdose or to administer drugs or devices approved or cleared under
the Federal Food, Drug, and Cosmetic Act for emergency treatment of
known or suspected opioid overdose without fear of civil or criminal
penalties.
This is not a formal request for application. Assistance will only
be provided to the Improving Access to Overdose Treatment Funding
Opportunity SP-18-006 grant recipients based on the receipt of a
satisfactory application and associated budget that is approved by a
review group.
Funding Opportunity Title: FY 2018 Improving Access to Overdose
Treatment Funding Opportunity SP-18-006.
Assistance Listing Number: 93.243.
Authority: Section 516 of the Public Health Services Act, as
amended.
Justification: Eligibility for this supplemental funding is limited
the Improving Access to Overdose Treatment Funding Opportunity SP-18-
006 grant recipients funded in FY 2018. These organizations are
uniquely positioned to provide training and technical assistance to
organizations and practitioners in prescription drug overdose
prevention activities being funded through this supplement.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-20436 Filed 9-20-22; 8:45 am]
BILLING CODE 4162-20-P
